WebApr 10, 2024 · The Cholesterol Lowering via Bempedoic Acid, an ACL-Inhibiting Regimen (CLEAR) Outcomes trial 1 was a company-funded, double-blind, randomized, placebo-controlled study conducted to determine the effects of bempedoic acid, an ATP citrate lyase inhibitor, on cardiovascular events in patients at high cardiovascular risk who were … WebMay 1, 2024 · To improve patient compliance with biofeedback training, the ACTICORE1 system was developed. It consists of a non-invasive sensor that detects pelvic floor …
ACTICORE1 - Apps on Google Play
WebActicor Biotech is a clinical stage biopharmaceutical company, a spin-off from INSERM (French National Institute of Health and Medical Research), which is developing an innovative “first in-class” treatment for cardiovascular emergencies, with a primary focus on Acute Ischemic Stroke. WebAdcore provides various solutions for outstanding digital marketing through our vision of ‘Effortless Marketing’. 2024 Growth Survey: Ad Spend, Opportunities, and Strategies for … dr hank ashford
ActorCore Sample Motions in Animations - UE …
WebThe company Acticore has developed and launched a therapy device for the pelvic floor muscles. The therapy is based on the sensor-technical recording of muscle activity and, together with a mobile app, enables various therapeutic exercises. joylab supported Acticore during the approval procedure as a medical device. WebImpressum: ACTICORE AG Steinengraben 81 4051 Basel [email protected] Umsatzsteueridentnr.: CHE-438.916.671 Handelsregister des Kantons Basel-Stadt Technischer Support +41 61 500 15 13 WebACTICORE1 – die Kontinenz-App ist ein digitales Home-Trainingsprogramm zur Stärkung deiner Beckenbodenmuskulatur. Deine Muskelbewegungen werden via Bluetooth auf deinem iOS oder Android-Device sichtbar gemacht. ANI – dein digitaler PersonalCoach - erstellt ein individuelles Trainingprogramm für dich. In den Warenkorb Lieferumfang dr hank cardinal